BCAL Diagnostics (ASX:BDX) ROE % Adjusted to Book Value : -20.47% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics ROE % Adjusted to Book Value?

BCAL Diagnostics's ROE % for the quarter that ended in Dec. 2023 was -85.35%. BCAL Diagnostics's PB Ratio for the quarter that ended in Dec. 2023 was 4.17. BCAL Diagnostics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -20.47%.

BCAL Diagnostics ROE % Adjusted to Book Value Historical Data

The historical data trend for BCAL Diagnostics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics ROE % Adjusted to Book Value Chart

BCAL Diagnostics Annual Data

Trend

Jun22

Jun23

ROE % Adjusted to Book Value

-20.18

-24.34

BCAL Diagnostics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial			-13.40	-22.31	-34.47	-29.05	-20.47

Competitive Comparison of BCAL Diagnostics's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, BCAL Diagnostics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BCAL Diagnostics's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BCAL Diagnostics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where BCAL Diagnostics's ROE % Adjusted to Book Value falls into.

BCAL Diagnostics ROE % Adjusted to Book Value Calculation

BCAL Diagnostics's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-68.16%	/	2.80
	=	-24.34%

BCAL Diagnostics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-85.35%	/	4.17
	=	-20.47%

BCAL Diagnostics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics (ASX:BDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230

Website

https://www.bcaldiagnostics.com

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.